Sylvester Researchers Find PARP Inhibitors Could Be a New Treatment for a Common Lymphoma - Healthcanal.com
Health Canal,
A study looking at PARP inhibition in diffuse large B cell lymphoma opens the door to a new way to treat this common type of…
LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL
Overview of attention for article published in Cancer Cell, August 2019
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (94th percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 113 Mendeley